Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312565502> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2312565502 abstract "Although initially striking, the therapeutic efficacy of BRAF inhibition is eventually undermined by adaptive cellular signaling that leads to progressive disease. To date, several mechanisms of BRAF inhibitor resistance have been reported focusing primarily on single alterations. To address how global rewiring of melanoma signaling promotes resistance, we utilized mass spectrometry based phosphoproteomic and network analyses to identify signaling changes in tyrosine, threonine and serine that occur prior to and following acquired BRAF inhibitor resistance. This comprehensive bioinformatics approach uncovered a “resistance interactome” consisting of ∼150 nodes that was marked by significant alterations and the emergence of signaling nodes such as ITGB1, EphA2, EphB4, FAK1, STAT3 and PXN. GeneGo pathway enrichment analysis revealed enhanced cytoskeletal rearrangement, adhesion, integrin signaling, cell migration and extracellular matrix remodeling. Consistent with our bioinformatic predictions, melanoma cell lines with acquired vemurafenib resistance were considerably more invasive than their drug naive counterparts and showed increased trans-endothelial cell migration. Confirmatory Western blot studies showed increased expression and phosphorylation of EphA2 receptor at Ser897, FAK1 at Ser397 and paxillin at Y118. Knockdown of EphA2 in the resistant cultures inhibited ERK signaling and completely prevented cell invasion and trans-endothelial cell migration. Functionally, EphA2 expression appeared to be regulated by an epigenetic mechanism involving promoter methylation and HDAC1. The clinical relevance of these findings was demonstrated in matched pairs of biopsies from patients receiving either BRAF or BRAF+MEK inhibitors, with significant Ephrin A2 receptor expression being observed in a subset of those on therapy. In summary, chronic MAPK pathway inhibition leads to major remodeling of the melanoma signaling network with EphA2 emerging as a key driver of the resistance phenotype. Citation Format: Kim H. T. Paraiso, Bin Fang, Dale Han, Inna Fedorenko, Jobin John, John Koomen, Jennifer Wargo, Keith Flaherty, Friedegund Meier, Kerian S. M. Smalley. Systems level modeling following BRAF inhibition reveals an essential role for Ephrin A2 receptor in therapeutic escape. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5237. doi:10.1158/1538-7445.AM2013-5237" @default.
- W2312565502 created "2016-06-24" @default.
- W2312565502 creator A5002876951 @default.
- W2312565502 creator A5023174631 @default.
- W2312565502 creator A5035338393 @default.
- W2312565502 creator A5035427219 @default.
- W2312565502 creator A5037516725 @default.
- W2312565502 creator A5066685499 @default.
- W2312565502 creator A5069267108 @default.
- W2312565502 creator A5074829574 @default.
- W2312565502 creator A5076672524 @default.
- W2312565502 creator A5089143575 @default.
- W2312565502 date "2013-04-15" @default.
- W2312565502 modified "2023-09-25" @default.
- W2312565502 title "Abstract 5237: Systems level modeling following BRAF inhibition reveals an essential role for Ephrin A2 receptor in therapeutic escape." @default.
- W2312565502 doi "https://doi.org/10.1158/1538-7445.am2013-5237" @default.
- W2312565502 hasPublicationYear "2013" @default.
- W2312565502 type Work @default.
- W2312565502 sameAs 2312565502 @default.
- W2312565502 citedByCount "0" @default.
- W2312565502 crossrefType "proceedings-article" @default.
- W2312565502 hasAuthorship W2312565502A5002876951 @default.
- W2312565502 hasAuthorship W2312565502A5023174631 @default.
- W2312565502 hasAuthorship W2312565502A5035338393 @default.
- W2312565502 hasAuthorship W2312565502A5035427219 @default.
- W2312565502 hasAuthorship W2312565502A5037516725 @default.
- W2312565502 hasAuthorship W2312565502A5066685499 @default.
- W2312565502 hasAuthorship W2312565502A5069267108 @default.
- W2312565502 hasAuthorship W2312565502A5074829574 @default.
- W2312565502 hasAuthorship W2312565502A5076672524 @default.
- W2312565502 hasAuthorship W2312565502A5089143575 @default.
- W2312565502 hasConcept C101544691 @default.
- W2312565502 hasConcept C150582083 @default.
- W2312565502 hasConcept C151166631 @default.
- W2312565502 hasConcept C170286479 @default.
- W2312565502 hasConcept C170493617 @default.
- W2312565502 hasConcept C195687474 @default.
- W2312565502 hasConcept C2776131300 @default.
- W2312565502 hasConcept C2777658100 @default.
- W2312565502 hasConcept C2781249067 @default.
- W2312565502 hasConcept C2994587330 @default.
- W2312565502 hasConcept C502942594 @default.
- W2312565502 hasConcept C54355233 @default.
- W2312565502 hasConcept C57074206 @default.
- W2312565502 hasConcept C62478195 @default.
- W2312565502 hasConcept C86803240 @default.
- W2312565502 hasConcept C95444343 @default.
- W2312565502 hasConceptScore W2312565502C101544691 @default.
- W2312565502 hasConceptScore W2312565502C150582083 @default.
- W2312565502 hasConceptScore W2312565502C151166631 @default.
- W2312565502 hasConceptScore W2312565502C170286479 @default.
- W2312565502 hasConceptScore W2312565502C170493617 @default.
- W2312565502 hasConceptScore W2312565502C195687474 @default.
- W2312565502 hasConceptScore W2312565502C2776131300 @default.
- W2312565502 hasConceptScore W2312565502C2777658100 @default.
- W2312565502 hasConceptScore W2312565502C2781249067 @default.
- W2312565502 hasConceptScore W2312565502C2994587330 @default.
- W2312565502 hasConceptScore W2312565502C502942594 @default.
- W2312565502 hasConceptScore W2312565502C54355233 @default.
- W2312565502 hasConceptScore W2312565502C57074206 @default.
- W2312565502 hasConceptScore W2312565502C62478195 @default.
- W2312565502 hasConceptScore W2312565502C86803240 @default.
- W2312565502 hasConceptScore W2312565502C95444343 @default.
- W2312565502 hasLocation W23125655021 @default.
- W2312565502 hasOpenAccess W2312565502 @default.
- W2312565502 hasPrimaryLocation W23125655021 @default.
- W2312565502 hasRelatedWork W1970323663 @default.
- W2312565502 hasRelatedWork W1984299335 @default.
- W2312565502 hasRelatedWork W2017298941 @default.
- W2312565502 hasRelatedWork W2182017987 @default.
- W2312565502 hasRelatedWork W2319356075 @default.
- W2312565502 hasRelatedWork W2322777413 @default.
- W2312565502 hasRelatedWork W2400597624 @default.
- W2312565502 hasRelatedWork W2402177453 @default.
- W2312565502 hasRelatedWork W2475701234 @default.
- W2312565502 hasRelatedWork W2566829743 @default.
- W2312565502 hasRelatedWork W2742109528 @default.
- W2312565502 hasRelatedWork W2768887441 @default.
- W2312565502 hasRelatedWork W2885192271 @default.
- W2312565502 hasRelatedWork W2887078648 @default.
- W2312565502 hasRelatedWork W2904506131 @default.
- W2312565502 hasRelatedWork W2953699178 @default.
- W2312565502 hasRelatedWork W2954402244 @default.
- W2312565502 hasRelatedWork W3004802074 @default.
- W2312565502 hasRelatedWork W3048305109 @default.
- W2312565502 hasRelatedWork W3081793128 @default.
- W2312565502 isParatext "false" @default.
- W2312565502 isRetracted "false" @default.
- W2312565502 magId "2312565502" @default.
- W2312565502 workType "article" @default.